A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAP

Sponsor
Current Health (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT05009485
Collaborator
South Shore Hospital (Other)
0
1
28

Study Details

Study Description

Brief Summary

Risk of rehospitalization within 30 days of discharge is higher than 20% in patients with chronic obstructive pulmonary disease (COPD) and up to 20% for patients with community acquired pneumonia (CAP). This pre-post intervention study aims to quantify the impact of continuous remote patient monitoring (RPM) on rates of hospital readmission for patients presenting with CAP or exacerbation of COPD and compare the intervention group to historical controls that did not have access to the intervention. We hypothesize that an intervention combining remote patient monitoring with the remote clinical services and escalation pathways available at SSH (including the Mobile Integrated Health (MIH) program) will reduce hospital readmission within the 30 days following hospital discharge compared to standard of care in this population.

Condition or Disease Intervention/Treatment Phase
  • Device: Current Health platform
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Pre-post Intervention Study Evaluating Home-based Management of Patients With Chronic Obstructive Pulmonary Disease or Community Acquired Pneumonia
Anticipated Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Participants will be remotely monitored with the Current Health platform, respond to daily respiratory surveys, receive daily medication reminders and an action plan. Daily dashboard rounds and vital sign alarms from the continuously collected vital signs will be used to identify changes in health and escalated accordingly.

Device: Current Health platform
A remote patient monitoring system which includes a small footprint device and tablet, combined with an AI-powered, cloud-based system driving advanced real-time and predictive analytics related to a patient's clinical condition. The wearable records heart rate, respiratory rate, oxygen saturation, skin temperature and step count.

Outcome Measures

Primary Outcome Measures

  1. Number of participants with a hospital readmission [up to 30 days]

Secondary Outcome Measures

  1. Time to service use [up to 30 days]

  2. Rate of clinical visits [up to 30 days]

    telehealth and/or ambulatory visits

  3. Length of Stay [up to 30 days]

    original and subsequent readmissions or emergency department attendance

  4. Rate of Mortality [up to 30 days]

  5. Rate of medication adherence [up to 30 days]

  6. Progression of Disease [up to 30 days]

    medication requirements, oxygen dependence, spirometric changes

Other Outcome Measures

  1. Patient Satisfaction as assessed by the Telehealth Usability Questionnaire [up to 30 days]

    subdomain of the Telehealth Usability Questionnaire that includes 4 questions measured on a 7-point Likert scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 21 years or older

  • confirmed diagnosis of moderate-severe COPD or community acquired pneumonia

  • attendance at South Shore Hospital with an exacerbation of COPD / CAP

  • fit for discharge to home

Exclusion Criteria:
  • suspicion of COVID-19 or confirmed COVID-19 positive

  • life-threatening exacerbation requiring invasive ventilation or prolonged stay in critical care (> 24 hours)

  • unable/unwilling to use Current Health

  • bilateral axillary lymph node dissection

  • persistent atrial fibrillation

  • heavy tattooing on upper arms

  • discharged to skilled nursing facility

  • no access to home or mobile telephone

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Current Health
  • South Shore Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Current Health
ClinicalTrials.gov Identifier:
NCT05009485
Other Study ID Numbers:
  • SSH_2021
First Posted:
Aug 17, 2021
Last Update Posted:
Nov 17, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Current Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2021